Processa Pharmaceuticals, Inc.
PCSA
$0.2294
-$0.0059-2.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.11% | -15.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.15% | 11.13% | |||
| Operating Income | 20.15% | -11.13% | |||
| Income Before Tax | 19.38% | -12.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.38% | -12.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.38% | -12.44% | |||
| EBIT | 20.15% | -11.13% | |||
| EBITDA | 20.16% | -11.12% | |||
| EPS Basic | 24.75% | -2.39% | |||
| Normalized Basic EPS | 24.75% | -2.38% | |||
| EPS Diluted | 24.75% | -2.39% | |||
| Normalized Diluted EPS | 24.75% | -2.38% | |||
| Average Basic Shares Outstanding | 7.14% | 9.81% | |||
| Average Diluted Shares Outstanding | 7.14% | 9.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||